Literature DB >> 22827710

Differences between objective efficacy and perceived efficacy in patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.

M A Alvarez1, J Ruano, F J Gómez, E Casas, C Baamonde, A Salvatierra, J C Moreno.   

Abstract

BACKGROUND: Moderate to severe palmar hyperhidrosis can disturb people's work and social and emotional lives. Botulinum toxin and sympathectomy are currently considered the most effective treatment options but few studies have analysed the concordance between efficacy and patient satisfaction in comparisons of these two types of treatments.
OBJECTIVE: To assess the relation between efficacy and the satisfaction of patients with palmar hyperhidrosis treated with either botulinum toxin or endoscopic thoracic sympathectomy.
MATERIAL AND METHODS: This retrospective, observational study included all patients treated with either botulinum toxin or endoscopic thoracic sympathectomy in a single reference hospital in 2005-2010. Information was obtained from computerized medical records and a telephone survey about patients' educational and socio-economic level, awareness of treatment options, pre- and post-treatment severity of palmar hyperhidrosis, satisfaction and associated side effects. Predictors of efficacy and patient satisfaction with each treatment were analysed with ordinal and multinomial logistic regression models.
RESULTS: Patients who underwent sympathectomy had more severe palmar hyperhidrosis but efficacy and patient satisfaction were greater compared with patients given botulinum toxin. The severity of the compensatory palmar hyperhidrosis was predictive of less satisfaction after sympathectomy. In the group treated with botulinum toxin, low socio-economic status, lack of information about treatment options, fewer sessions and a shorter anhidrotic effect were associated with less satisfaction.
CONCLUSION: In studies of expectations regarding the outcome of palmar hyperhidrosis treatment, doctors should consider the factors that determine patient satisfaction in relation to the treatment options.
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22827710     DOI: 10.1111/j.1468-3083.2012.04630.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  3 in total

1.  Economic evaluation of botulinum toxin versus thoracic sympathectomy for palmar hyperhidrosis: data from a real-world scenario.

Authors:  Beatriz Isla-Tejera; Juan Ruano; María A Alvarez; Teresa Brieva; Manuel Cárdenas; Carlos Baamonde; Angel Salvatierra; José-Ramón Del Prado-Llergo; José C Moreno-Giménez
Journal:  Dermatol Ther (Heidelb)       Date:  2013-05-14

2.  New trends in botulinum toxin use in dermatology.

Authors:  Stefania Guida; Francesca Farnetani; Steven P Nisticò; Caterina Giorgio Mariarosaria; Graziella Babino; Giovanni Pellacani; Elisabetta Fulgione
Journal:  Dermatol Pract Concept       Date:  2018-10-31

3.  Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.

Authors:  Adelaide A Hebert; Dee Anna Glaser; Lawrence Green; William P Werschler; Douglass W Forsha; Janice Drew; Ramanan Gopalan; David M Pariser
Journal:  Pediatr Dermatol       Date:  2018-11-19       Impact factor: 1.588

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.